Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026)
Lucid Diagnostics (LUCD) posted Retained Earnings of -$298.0 million for Q1 2026, down 8.61% on a QoQ basis from -$274.3 million in Q4 2025, and down 24.26% year-over-year from -$393.4 million in Q1 2025.
Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$298.0 million for Q1 2026.
- Quarterly Retained Earnings fell 24.26% year-over-year to -$298.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$298.0 million (down 24.26% YoY) and the FY2025 annual result came in at -$274.3 million, down 34.63% from the prior year.
- Retained Earnings was -$298.0 million for Q1 2026 at Lucid Diagnostics, down from -$274.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $201.0 million in Q2 2025 and bottomed at -$298.0 million in Q1 2026.
- A 5-year average of -$54.5 million and a median of -$83.1 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings surged 388.95% — and 2025, when it plunged 280.98%.
- Lucid Diagnostics' Retained Earnings stood at $121.1 million in 2022, then tumbled by 224.5% to -$150.7 million in 2023, then slumped by 35.18% to -$203.8 million in 2024, then sank by 34.63% to -$274.3 million in 2025, then decreased by 8.61% to -$298.0 million in 2026.
- Business Quant data shows LUCD's Retained Earnings at -$298.0 million in Q1 2026, -$274.3 million in Q4 2025, and -$258.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -297.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -297.96 Mn |
| Dec 31, 2025 | -274.34 Mn |
| Sep 30, 2025 | -258.07 Mn |
| Jun 30, 2025 | 201.01 Mn |
| Mar 31, 2025 | -239.78 Mn |
| Dec 31, 2024 | -203.77 Mn |
| Sep 30, 2024 | 142.59 Mn |
| Jun 30, 2024 | -179.85 Mn |
| Mar 31, 2024 | 136.41 Mn |
| Dec 31, 2023 | -150.74 Mn |
| Sep 30, 2023 | 128.80 Mn |
| Jun 30, 2023 | -125.70 Mn |
| Mar 31, 2023 | 125.56 Mn |
| Dec 31, 2022 | 121.08 Mn |
| Sep 30, 2022 | -83.15 Mn |
| Jun 30, 2022 | -68.80 Mn |
| Mar 31, 2022 | 100.63 Mn |
| Dec 31, 2021 | -41.90 Mn |
| Sep 30, 2021 | -30.60 Mn |
| Dec 31, 2020 | 294,000.00 |